These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study. Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980 [TBL] [Abstract][Full Text] [Related]
4. Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide. Benucci M; Li Gobbi F; Panconesi P; Manfredi M; Sarzi-Puttini P; Atzeni F Reumatismo; 2013 May; 65(2):90-4. PubMed ID: 23877415 [TBL] [Abstract][Full Text] [Related]
5. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Knight A; Askling J; Granath F; Sparen P; Ekbom A Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900 [TBL] [Abstract][Full Text] [Related]
6. Wegener's granulomatosis presenting as meningitis. Thiel G; Shakeel M; Ah-See K J Laryngol Otol; 2012 Feb; 126(2):207-9. PubMed ID: 21914245 [TBL] [Abstract][Full Text] [Related]
7. Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab. Staines KS; Higgins B Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):76-80. PubMed ID: 19451001 [TBL] [Abstract][Full Text] [Related]
8. [Wegener's granulomatosis and microscopic polyangiitis]. Pagnoux C Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109 [TBL] [Abstract][Full Text] [Related]
9. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864 [TBL] [Abstract][Full Text] [Related]
10. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment]. Novikov PI; Krivosheev OG; Semenkova EN Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891 [TBL] [Abstract][Full Text] [Related]
13. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report. Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations. Seo P; Specks U; Keogh KA J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911 [TBL] [Abstract][Full Text] [Related]
15. Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab. Malm IJ; Mener DJ; Kim J; Seo P; Kim YJ Otolaryngol Head Neck Surg; 2014 Jan; 150(1):68-72. PubMed ID: 24154746 [TBL] [Abstract][Full Text] [Related]
16. Etanercept plus standard therapy for Wegener's granulomatosis. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of rituximab in refractory Wegener's granulomatosis with central nervous system involvement]. Kowalewska B; Krywejko J; Roszkowska E Ann Acad Med Stetin; 2010; 56 Suppl 1():99-104. PubMed ID: 21365953 [TBL] [Abstract][Full Text] [Related]
19. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment. Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261 [No Abstract] [Full Text] [Related]
20. [Infectious aspects of Wegener's granulomatosis]. Rusterholz D; Schlegel C Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]